Literature DB >> 27591495

Management of Sarcoma Metastases to the Lung.

Christopher S Digesu1, Ory Wiesel1, Ara A Vaporciyan2, Yolonda L Colson3.   

Abstract

For decades, surgical resection of pulmonary metastases has been performed; despite limited randomized data, surgery is increasingly accepted as an integral part in the management of metastatic disease. Long-term results indicate resection is potentially curative with significantly improved survival following complete resection. Recurrence, however, is not uncommon with many patients undergoing repeat resection. With advancing surgical technique and adjuvant therapies, patients with high or recurrent tumor burden are increasingly afforded disease control and potential cure. In this review, the prognostic characteristics of pulmonary metastases from sarcoma, preoperative evaluation, operative technique, long-term outcomes, and management of complex patients are highlighted.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Prognostic factors; Pulmonary metastasectomy; SBRT; Sarcoma; Thoracic surgery; VATS

Mesh:

Year:  2016        PMID: 27591495      PMCID: PMC5028117          DOI: 10.1016/j.soc.2016.05.005

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN: 1055-3207            Impact factor:   3.495


  60 in total

1.  Long-term survival of a phase I clinical trial of isolated lung perfusion with melphalan for resectable lung metastases.

Authors:  Willem A Den Hengst; Bart P Van Putte; Jeroen M H Hendriks; Bernard Stockman; Wim-Jan P van Boven; Joost Weyler; Franz M N H Schramel; Paul E Y Van Schil
Journal:  Eur J Cardiothorac Surg       Date:  2010-05-15       Impact factor: 4.191

2.  Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases.

Authors:  U Pastorino; M Buyse; G Friedel; R J Ginsberg; P Girard; P Goldstraw; M Johnston; P McCormack; H Pass; J B Putnam
Journal:  J Thorac Cardiovasc Surg       Date:  1997-01       Impact factor: 5.209

3.  Pulmonary resection of metastatic sarcoma: prognostic factors associated with improved outcomes.

Authors:  Samuel Kim; Harald C Ott; Cameron D Wright; John C Wain; Christopher Morse; Henning A Gaissert; Dean M Donahue; Douglas J Mathisen; Michael Lanuti
Journal:  Ann Thorac Surg       Date:  2011-10-31       Impact factor: 4.330

4.  A 10-year single-center experience on 708 lung metastasectomies: the evidence of the "international registry of lung metastases".

Authors:  Monica Casiraghi; Tommaso De Pas; Patrick Maisonneuve; Daniela Brambilla; Barbara Ciprandi; Domenico Galetta; Alessandro Borri; Roberto Gasparri; Francesco Petrella; Adele Tessitore; Juliana Guarize; Stefano Maria Donghi; Giulia Veronesi; Piergiorgio Solli; Lorenzo Spaggiari
Journal:  J Thorac Oncol       Date:  2011-08       Impact factor: 15.609

5.  Pulmonary metastasectomy and repeat metastasectomy for soft-tissue sarcoma.

Authors:  Mehdi Seilanian Toussi; Reza Bagheri; Mahdieh Dayani; Kazem Anvari; Shima Sheibani
Journal:  Asian Cardiovasc Thorac Ann       Date:  2013-07-09

6.  Factors associated with actual long-term survival following soft tissue sarcoma pulmonary metastasectomy.

Authors:  R Smith; Y Pak; W Kraybill; J M Kane
Journal:  Eur J Surg Oncol       Date:  2008-02-21       Impact factor: 4.424

7.  Cost-effectiveness of pulmonary resection and systemic chemotherapy in the management of metastatic soft tissue sarcoma: a combined analysis from the University of Texas M. D. Anderson and Memorial Sloan-Kettering Cancer Centers.

Authors:  Geoffrey A Porter; Scott B Cantor; Garrett L Walsh; Valerie W Rusch; Dennis H Leung; Alma Y DeJesus; Raphael E Pollock; Murray F Brennan; Peter W T Pisters
Journal:  J Thorac Cardiovasc Surg       Date:  2004-05       Impact factor: 5.209

8.  Roles of positron emission tomography with fluorine-18-deoxyglucose in the detection of local recurrent and distant metastatic sarcoma.

Authors:  Germaine R Johnson; Hongming Zhuang; Jehanzeb Khan; Stephen B Chiang; Abass Alavi
Journal:  Clin Nucl Med       Date:  2003-10       Impact factor: 7.794

9.  Stereotactic Radiotherapy in the Treatment of Lung Metastases from Bone and Soft-tissue Sarcomas.

Authors:  Rezarta Frakulli; Fabrizio Salvi; Damiano Balestrini; Alessandro Parisi; Marcella Palombarini; Silvia Cammelli; Michele Rocca; Mariacristina Salone; Alessandra Longhi; Stefano Ferrari; Alessio G Morganti; Giovanni Frezza
Journal:  Anticancer Res       Date:  2015-10       Impact factor: 2.480

10.  Thoracoscopic lung metastasectomies: a 10-year, single-center experience.

Authors:  Felice Lo Faso; Luciano Solaini; Rosalba Lembo; Paolo Bagioni; Silvia Zago; Paolo Soliani; Robert D Pascotto
Journal:  Surg Endosc       Date:  2013-01-24       Impact factor: 4.584

View more
  15 in total

Review 1.  Image-Guided Thermal Ablative Therapies in the Treatment of Sarcoma.

Authors:  Scott M Thompson; John J Schmitz; Grant D Schmit; Matthew R Callstrom; Anil Nicholas Kurup
Journal:  Curr Treat Options Oncol       Date:  2017-04

2.  A novel anti-CD47-targeted blockade promotes immune activation in human soft tissue sarcoma but does not potentiate anti-PD-1 blockade.

Authors:  Andrej Ozaniak; Jitka Smetanova; Robin Bartolini; Michal Rataj; Linda Capkova; Jaromir Hacek; Martina Fialova; Lenka Krupickova; Ilja Striz; Robert Lischke; Jirina Bartunkova; Zuzana Strizova
Journal:  J Cancer Res Clin Oncol       Date:  2022-08-20       Impact factor: 4.322

3.  Impact of Intraoperative Molecular Imaging after Fluorescent-Guided Pulmonary Metastasectomy for Sarcoma.

Authors:  Feredun Azari; Gregory T Kennedy; Kevin Zhang; Elizabeth Bernstein; Robert G Maki; Colleen Gaughan; Doraid Jarrar; Taine Pechet; John Kucharczuk; Sunil Singhal
Journal:  J Am Coll Surg       Date:  2022-05-01       Impact factor: 6.532

Review 4.  Pulmonary metastasectomy: an overview.

Authors:  Francesco Petrella; Cristina Diotti; Arianna Rimessi; Lorenzo Spaggiari
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

Review 5.  Survival and prognostic factors following pulmonary metastasectomy for sarcoma.

Authors:  Giuseppe Marulli; Marco Mammana; Giovanni Comacchio; Federico Rea
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

6.  Is Repeat Pulmonary Metastasectomy Indicated for Soft Tissue Sarcoma?

Authors:  Neel P Chudgar; Murray F Brennan; Kay See Tan; Rodrigo R Munhoz; Sandra P D'Angelo; Manjit S Bains; James Huang; Bernard J Park; Prasad S Adusumilli; William D Tap; David R Jones
Journal:  Ann Thorac Surg       Date:  2017-11-02       Impact factor: 4.330

7.  Linear mixed-effects models for estimation of pulmonary metastasis growth rate: implications for CT surveillance in patients with sarcoma.

Authors:  Ulysses Isidro; Liam M O'Brien; Ronnie Sebro
Journal:  Br J Radiol       Date:  2020-08-26       Impact factor: 3.039

8.  Intimal sarcoma of the pulmonary artery with multiple lung metastases: Long-term survival case.

Authors:  Sonia García-Cabezas; Macarena Centeno-Haro; Simona Espejo-Pérez; Elvira Carmona-Asenjo; Alberto L Moreno-Vega; Rosa Ortega-Salas; Amalia Palacios-Eito
Journal:  World J Clin Oncol       Date:  2017-08-10

9.  Significant benefit of Nivolumab treating PD-L1 positive metastatic pulmonary carcinosarcoma: a case report and literature review.

Authors:  Zhe Zhang; Yishan Chen; Mingxia Ma; Junli Hao; Rui Ding; Lixin Han; Jiayun Zou; Lina Zhang; Qin Meng; Xiujuan Qu; Yunpeng Liu; Mingfang Zhao
Journal:  Oncotarget       Date:  2017-07-07

10.  Malignant peripheral nerve sheath tumours in magnetic resonance imaging: primary and recurrent tumour appearance, post-treatment changes, and metastases.

Authors:  Sam Sedaghat; Frederick Schmitz; Martin Grözinger; Maya Sedaghat
Journal:  Pol J Radiol       Date:  2020-04-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.